Privacy professionalsfromwww.bbc.com2 weeks agoStruggling DNA testing firm 23andMe to be bought for $256m23andMe is being acquired by Regeneron Pharmaceuticals for $256 million post-bankruptcy, ensuring continued privacy protections for users.
Marketing techfromwww.aljazeera.com2 weeks agoRegeneron buys 23andMe for $256m after bankruptcyRegeneron's acquisition of 23andMe raises significant privacy concerns regarding the genetic data of millions of customers.
Marketing techfromFuturism2 weeks agoBankrupt 23andMe Just Sold Off All Your DNA DataRegeneron Pharmaceuticals is acquiring 23andMe, raising significant data privacy concerns over consumer genetic information.
Marketing techfromwww.ocregister.com2 weeks agoBiotech company Regeneron buying 23andMe for $256 millionRegeneron acquires 23andMe for $256 million following its bankruptcy filing, aiming to enhance genetic insights while ensuring user privacy.
Startup companiesfromBusiness Insider2 weeks ago23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.Regeneron Pharmaceuticals is acquiring 23andMe's assets for $256 million following the company's bankruptcy.
fromFast Company6 days agoStartup companies23andMe's Anne Wojcicki moves to reopen auction with support from a Fortune 500 company
Privacy professionalsfromwww.bbc.com2 weeks agoStruggling DNA testing firm 23andMe to be bought for $256m23andMe is being acquired by Regeneron Pharmaceuticals for $256 million post-bankruptcy, ensuring continued privacy protections for users.
Marketing techfromwww.aljazeera.com2 weeks agoRegeneron buys 23andMe for $256m after bankruptcyRegeneron's acquisition of 23andMe raises significant privacy concerns regarding the genetic data of millions of customers.
Marketing techfromFuturism2 weeks agoBankrupt 23andMe Just Sold Off All Your DNA DataRegeneron Pharmaceuticals is acquiring 23andMe, raising significant data privacy concerns over consumer genetic information.
Marketing techfromwww.ocregister.com2 weeks agoBiotech company Regeneron buying 23andMe for $256 millionRegeneron acquires 23andMe for $256 million following its bankruptcy filing, aiming to enhance genetic insights while ensuring user privacy.
Startup companiesfromBusiness Insider2 weeks ago23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.Regeneron Pharmaceuticals is acquiring 23andMe's assets for $256 million following the company's bankruptcy.
fromFast Company6 days agoStartup companies23andMe's Anne Wojcicki moves to reopen auction with support from a Fortune 500 company
